Human papillomavirus in oropharyngeal squamous cell carcinomas in korea: Use of G1 cycle markers as new prognosticators

Head and Neck

Volumn 34, Issue 10, 2012, Pages 1408-1417

  Park, Weon Seo ^a   Ryu, Junsun ^b   Cho, Kwan Ho ^b   Choi, Moon Kyung ^a   Moon, Sung Ho ^b   Yun, Tak ^b   Chun, Byung Sam ^b   Lee, Geon Kook ^a   Ahn, Hyun Joo ^c   Lee, John H ^c   Vermeer, Paola ^c   Jung, Yuh Seog ^b  

^a National Cancer Center   (South Korea)

^b Hematologic Oncology Clinic   (South Korea)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

CCND1 protein; cdk4 protein; human papillomavirus; oropharyngeal cancer; p16 protein

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL CYCLE; CELL CYCLE G1 PHASE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KOREA; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866407102     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21939     Document Type: Article

References (22)

1. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720. (Pubitemid 30365531)
2. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630-5636. (Pubitemid 46631302)
3. Ernster JA, Sciotto CG, O'Brien MM, et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 2007; 117: 2115-2128. (Pubitemid 351339584)
4. Termine N, Panzarella V, Falaschini S, et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol 2008; 19: 1681-1690.
5. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009; 125: 362-366.
6. de Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7: 453-459. (Pubitemid 46962343)
7. Settle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila Pa) 2009; 2: 776-781.
8. Zhang HS, Postigo AA, Dean DC,. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell 1999; 97: 53-61.
9. Zou X, Ray D, Aziyu A, et al. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Genes Dev 2002; 16: 2923-2934. (Pubitemid 35334740)
10. Li Y, Nichols MA, Shay JW, Xiong Y,. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994; 54: 6078-6082. (Pubitemid 24378633)
11. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT,. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 1993; 53: 5535-5541. (Pubitemid 23342180)
12. Ghazizadeh M, Jin E, Shimizu H, et al. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas. Respiration 2005; 72: 68-73. (Pubitemid 40470280)
13. Greene FL, Balsh CM, Haller DG, Morrow M,. AJCC Cancer Staging Manual. In:, Greene FL, editor. 6th ed: Springer; 2002.
14. Barnes L, Eveson JW, Reichart P, Sidransky D,. Pathology and genetics of head and neck tumours (IARC WHO Classification of Tumours). Lyon: IARC Press; 2005.
15. Buccheri G, Ferrigno D, Tamburini M,. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996; 32A: 1135-1141.
16. Choi YD, Jung WW, Nam JH, Choi HS, Park CS,. Detection of HPV genotypes in cervical lesions by the HPV DNA chip and sequencing. Gynecol Oncol 2005; 98: 369-375.
17. Obermann EC, Marienhagen J, Stoehr R, Wuensch PH, Hofstaedter F,. Tissue microarray construction from bone marrow biopsies. Biotechniques 2005; 39: 822, 824, 826.
18. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747. (Pubitemid 46622040)
19. Caldeira S, de Villiers EM, Tommasino M,. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein. Oncogene 2000; 19: 821-826. (Pubitemid 30107713)
20. Collins AS, Nakahara T, Do A, Lambert PF,. Interactions with pocket proteins contribute to the role of human papillomavirus type 16 E7 in the papillomavirus life cycle. J Virol 2005; 79: 14769-14780. (Pubitemid 41636275)
21. Li W, Thompson CH, Cossart YE, et al. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 2004; 26: 1-9. (Pubitemid 38030143)
22. Almadori G, Galli J, Cadoni G, Bussu F, Maurizi M,. Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance. Head Neck 2002; 24: 597-604. (Pubitemid 34575344)